Navigation Links
Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
Date:6/5/2013

HAYWARD, Calif., June 5, 2013 /PRNewswire/ -- Rafael Simon, a veteran in the environment and energy industries, has joined Microvi Biotechnologies as Chairman of its Board of Directors. Rafael was the COO of Zenon Environmental, a leading water treatment company, previous to its acquisition by GE Water in 2006 for nearly $700 M.

(Photo: http://photos.prnewswire.com/prnh/20130605/PH26398 )

While at Zenon, Rafael was responsible for all aspects of sales, operations, R&D and manufacturing. During his tenure at Zenon, share price tripled and he was named Canada's top COO by Canadian Business, Canada's leading business magazine.

"Rafael brings expertise in strategy and a depth of knowledge in our market focus that will be important in Microvi's continuing commercialization of its MicroNiche Engineering Platform Technology," said Dr. Fatemeh Shirazi , CEO of Microvi. "I am delighted to welcome him as Chairman of Microvi's Board of Directors."

He joins Microvi at a pivotal growth period, building on successful scaling and commercialization of the company's platform technology and various biocatalytic solutions for clean water, renewable biofuels, biochemicals and other industrial bioprocesses.

"I'm excited to have the opportunity to help scale-up the revolutionary Microvi biocatalyst technology which has the potential to disrupt so many industries," said Rafael.

Previous to his work with Zenon, Rafael worked at McKinsey & Company specializing in corporate growth strategies for water and energy companies.  Rafael currently serves as director on a number of boards internationally and received his Ph.D. in Materials Science and Mineral Engineering from the University of California, Berkeley.

About Microvi

Microvi is a leading biotechnology company that discovers, develops, manufactures, and commercializes innovative biocatalytic technologies in water, energy and chemical industries. Microvi's pipeline of solutions, created using its proprietary MicroNiche Engineering™ platform, enable cost-effective economics, are energy efficient and waste free and deliver higher performance than conventional methods. To learn more please visit www.microvi.com.

Media Contact:

Karin Kidder , Microvi Biotechnologies, 1-510-344-0668
Email

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Microvi
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Microvi and Aquatech Break Ground on Large Demonstration System at Aerojet Site in Rancho Cordova, CA
2. Dr. Gerald Jerry Zon Launches New Blog for TriLink BioTechnologies
3. TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S, Copenhagen, Denmark
4. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
5. TriLink BioTechnologies Awards Keck Science Department ResearchReward
6. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
7. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
8. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
9. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
10. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
11. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2020)... YORK (PRWEB) , ... May 29, 2020 , ... ... of Chief Medical Officer 360°, the first newsletter solely dedicated to the unique ... capture a wide range of perspectives on the responsibilities, problem-solving, best practices and ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... will cause long-term harm , Contrary to conventional wisdom that says the coronavirus ... finds many companies will emerge from the pandemic commercially weaker, dealing with delays ...
(Date:5/15/2020)... (PRWEB) , ... May 14, ... ... supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC ... to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC ...
(Date:5/14/2020)... WILMINGTON, Del. (PRWEB) , ... May 12, 2020 ... ... selection of Interdisp JCS as the new distribution partner for all personal care ... the DuPont GENENCARE®OSMS portfolio and DuPont preservative portfolio for personal care. , ...
Breaking Biology Technology:
(Date:5/28/2020)... ... May 28, 2020 , ... Actuate Therapeutics, Inc. ... 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) will be presented at this ... virtually on May 29th, 2020. Dr. Benedito Carneiro, Brown University’s principal investigator on ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... background and medical screening, announces the launch of a testing service aimed ... safe. The new service is provided by ClearStar’s Medical Information Services (“MIS”) ...
(Date:5/21/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... May 20, 2020 , ... ... justice, and remove danger for all of us. The positions of these men and ... as from the defense for not following rules precisely. Officers have always had to ...
Breaking Biology News(10 mins):